Comparisons of Assays for Monitoring of Glycemic Control in Diabetes

Review of A1C, Glycated Albumin, and Fructosamine
 

Tuesday, July 26
3:30 – 4:30 p.m.
Exhibit Hall Theater 1
Supported by EKF Diagnostics

Overview

Tests of glycated proteins, along with glucose, have been available for decades for the diagnosis and monitoring of diabetes mellitus. Hemoglobin A1C is considered to be the gold standard test and is used in the diagnosis, monitoring, and as the established risk predictor for complications. However, there are conditions that may adversely affect the HbA1c values and may result in inaccurate or misleading values. Alternative index tests such as fructosamine and glycated albumin (GA) may be appropriate in certain diabetic subpopulations. We will explore the strengths and limitations of different glycemic tests and introduce a new enzymatic method for GA.

Outcomes

After attending this session, participants will be able to:

  • Understand the need for alternate glycemic tests and the clinical indications or sub-populations when they might be ordered or appropriate.
  • Describe the evolution, architecture, and technique of the GA test for use in glycemic monitoring of diabetes mellitus and its ability in predicting risk for diabetic complications.
  • Recognize the differences and similarities of GA to other commonly used glycemic index tests used with diabetics.

Moderator

William Shorter
Global Product Manager - Diabetes


Speaker

Shane O’Neil
Global Director, Scientific Affairs

Takuji Kohzuma, PhD
Senior Manager
Asahi Kasei Pharma Corporation